Abiraterone

Steroid Use With Abiraterone Offers Multidimensional Benefits to Patients With …
For decades, the standard of care for men with advanced prostate cancer has been the depletion or inhibition of androgens. While androgen-deprivation therapy (ADT) often results in temporary tumor regression or symptom relief in some patients, disease ... [...]
4
Like
Save
Abiraterone acetate in metastatic castration-resistant prostate cancer – the …
We report the clinical outcome of metastatic castration-resistant prostate cancer (mCRPC) patients treated with AA in real-life clinical practice. The clinical records of mCRPC patients treated with AA from all 6 public oncology centers in Hong Kong ... [...]
4
Like
Save
Dr. Crawford on Abiraterone Versus Enzalutamide in Prostate Cancer
E. David Crawford, MD, professor of Radiation Oncology, Department of Surgery, University of Colorado Denver, discusses factors in selecting treatment with abiraterone acetate (Zytiga) versus enzalutamide (Xtandi) for patients with castration-resistant ... [...]
4
Like
Save
Abiraterone Acetate Plus Prednisone Demonstrates OS Benefit in Prostate Cancer
An abiraterone acetate (Zytiga) plus prednisone combination showcased an 11.8-month improvement in overall survival (OS) when compared with prednisone and placebo in less advanced, chemotherapy-naïve metastatic castration-resistant prostate cancer ... [...]
2
Like
Save
Abiraterone Acetate
Symptoms of prostate cancer include urinary problems like a slow or weak urinary stream or the need to urinate more often, especially at night, blood in the urine, erectile dysfunction, pain in the hips, back, chest, or other areas from cancer spread ... [...]
7
Like
Save
ASCO GU 2016 Evaluating abiraterone responses in African Americans with …
In total 103 men with metastatic castration-resistant prostate cancer (mCRPC) were treated with abiraterone during the period of the study, including 24 African American men and 79 Caucasian men. Men had similar baseline age (61.8 years for African ... [...]
1
Like
Save
Statins Boost Abiraterone Activity in Prostate Cancer
SAN FRANCISCO ― Statin use may prolong the duration of abiraterone acetate (Zytiga, Janssen Pharmaceuticals, Inc) treatment in men with castration-resistant prostate cancer (CRPC), according to new findings presented here at Genitourinary Cancers ... [...]
6
Like
Save